National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 41458 [06-6398]

Download as PDF 41458 Federal Register / Vol. 71, No. 140 / Friday, July 21, 2006 / Notices Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) The accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) Ways to enhance the quality, utility, and clarity of the information to be collected; and (d) Ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Jan Lipkin, Project Officer, National Institute on Drug Abuse, NIDA/NIH/ DHHS, 6001 Executive Boulevard, Room 5219, Bethesda, MD 20852; or call nontoll-free number (301) 443–1124; fax (301) 443–7397; or e-mail your request, including your address to: jlipkin@nida.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. Dated: July 14, 2006. Laura Rosenthal, Associate Director for Management, National Institute on Drug Abuse. [FR Doc. E6–11614 Filed 7–20–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES rwilkins on PROD1PC63 with NOTICES_1 National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. 17:59 Jul 20, 2006 Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Mucosal Immune System: Infection and Inflammation. Date: August 10, 2006. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3131, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Katherine L. White, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301–435–1615, kw174b@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: July 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–6397 Filed 7–20–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, NINDS Clinical Trials SEP. Date: August 7, 2006. Time: 8:30 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Chevy Chase, at Chevy Chase Pavillion, 4300 Military Road, NW., Washington, DC. Contact Person: Shantadurga Rajaram, PhD, Scientific Review Administrator, Scientific Review Branch, NIH/NINDS/ Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20852, (301) 435–6033, rajarams@mail.nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, CounterACT–U01. Date: August 9–10, 2006. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Willard Intercontinental Hotel, 1401 Pennsylvania Avenue, Washington, DC 20004. Contact Person: Richard D. Crosland, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, (301) 594–0635, rc218u@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: July 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–6398 Filed 7–20–06; 8:45 am] BILLING CODE 4140–01–M Jkt 208001 National Institutes of Health DEPARTMENT OF HOMELAND SECURITY National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings BILLING CODE 4140–01–P VerDate Aug<31>2005 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Coast Guard Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 [USCG–2006–24525] Collection of Information Under Review by Office of Management and Budget: OMB Control Number 1625– 0087 Coast Guard, DHS. Request for comments. AGENCY: ACTION: SUMMARY: In compliance with the Paperwork Reduction Act of 1995, this request for comments announces that the Coast Guard is forwarding one Information Collection Request (ICR), E:\FR\FM\21JYN1.SGM 21JYN1

Agencies

[Federal Register Volume 71, Number 140 (Friday, July 21, 2006)]
[Notices]
[Page 41458]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6398]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel, NINDS Clinical Trials SEP.
    Date: August 7, 2006.
    Time: 8:30 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites Chevy Chase, at Chevy Chase Pavillion, 
4300 Military Road, NW., Washington, DC.
    Contact Person: Shantadurga Rajaram, PhD, Scientific Review 
Administrator, Scientific Review Branch, NIH/NINDS/Neuroscience 
Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 
20852, (301) 435-6033, rajarams@mail.nih.gov.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel, CounterACT-U01.
    Date: August 9-10, 2006.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Willard Intercontinental Hotel, 1401 Pennsylvania Avenue, 
Washington, DC 20004.
    Contact Person: Richard D. Crosland, PhD, Scientific Review 
Administrator, Scientific Review Branch, Division of Extramural 
Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Blvd., 
Suite 3208, MSC 9529, Bethesda, MD 20892-9529, (301) 594-0635, 
rc218u@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: July 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6398 Filed 7-20-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.